Blood donor restrictions regarding variant Creutzfeldt-Jakob disease are scientifically justified
the verdict
SUPPORTED
the evidence backs this
confidence 86/100
Scientific literature and public health risk assessments support blood donor restrictions for variant Creutzfeldt-Jakob disease due to documented risks of transfusion transmission and long asymptomatic incubation periods.
Evidence for · 4
Variant Creutzfeldt–Jakob disease: risk of transmission by blood transfusion and blood therapies
2006 · cited by 62
Highlights that vCJD can be transmitted via blood transfusion, justifying precautions like donor restrictions given long incubation periods and lack of reliable screening.
See more details
More for · 3
The success of precaution? Managing the risk of transfusion transmission of variant Creutzfeldt‐Jakob disease
2004 · cited by 29
Shows that preventative blood safety policies regarding vCJD were successfully instituted using the precautionary principle in the face of transmission risks.
Variant Creutzfeldt-Jakob disease surveillance in Spain, 1993-2021.
2026 · cited by 0
Notes that variant Creutzfeldt-Jakob disease can be transmitted through blood transfusions, supporting measures to screen or restrict donors.
Estimating future variant Creutzfeldt-Jakob disease cases in the UK: a cohort-based probabilistic model.
2025 · cited by 0
Indicates that secondary transmission risks remain low specifically because of core blood safety policies and maintenance of donor restrictions.